Jennifer Hayes, MD
Procedural Dermatology · Santa Rosa, CANPI 1649599648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 38.2% of the total.
Across 148 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$465
- Novartis$256
- Arcutis Biotherapeutics, Inc.$236
- Pfizer$208
- Lilly USA, LLC$122
- plus $621 from 10 others
What the payments were for
- Food & beverage$3,073100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,179 |
| Johnson & Johnson | 19 | $465 |
| Novartis | 13 | $256 |
| Arcutis Biotherapeutics, Inc. | 14 | $236 |
| Pfizer | 10 | $208 |
| Lilly USA, LLC | 5 | $122 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| UCB, Inc. | 4 | $90 |
| Amgen | 3 | $88 |
| Galderma Laboratories, L.p. | 3 | $72 |
| Sanofi | 3 | $65 |
| LEO Pharma Inc. | 3 | $61 |
| Sun Pharmaceutical Industries Inc. | 2 | $47 |
| Incyte Corporation | 2 | $43 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| Strata Skin Sciences, Inc. | 2 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$119
How this compares
$3,088 in reported general payments places this provider in the 55th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 21 | $71,953 |
| Clobetasol Propionate | 52 | $2,228 |
| Tretinoin | 17 | $788 |
| Triamcinolone Acetonide | 48 | $528 |
| Doxycycline Hyclate | 14 | $490 |
| Clindamycin Phosphate | 12 | $308 |
| Hydrocortisone | 21 | $214 |
| Ketoconazole | 23 | $194 |
| Minoxidil | 18 | $108 |
| Mupirocin | 15 | $39 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Santa Rosa
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Jeanette BlackLos Angeles$492K
- Mitchel GoldmanSan Diego$425K
- Rebecca FitzgeraldLos Angeles$230K
- Suzanne KilmerSacramento$220K
- Zakia RahmanStanford$181K
- Hrak JalianSanta Monica$160K
- Amelia HausauerCampbell$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.